Psychedelics Investing

Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses Enveric Biosciences (NASDAQ: ENVB) has created an Australia-based subsidiary, Enveric Therapeutics, to support its next-generation psychedelics program for anxiety disorders. FSD Pharma Inc.'s (NASDAQ: HUGE) Australian...

Early-stage psychedelics manufacturing company Lucy Scientific Discovery Inc. (NASDAQ: LSDI) partnered with specialized firm Pramantha Group to obtain key government contracts and grants that would enhance its drug manufacturing capabilities to meet the growing demand. See Also: Lucy...

FSD Pharma Inc. (NASDAQ: HUGE) has renewed a service agreement with shareholder intelligence services provider ShareIntel LLC to assist in ongoing investigations related to suspected naked short selling of the company’s common stock. Over recent years, FSD Pharma’s management received...

Clinical-stage biopharma company Reunion Neuroscience Inc. (NASDAQ: REUN) filed a lawsuit against drug discovery business Mindset Pharma Inc. (OTCQB: MSSTF) in the District Court of New Jersey. Reunion alleges that Mindset purposefully copied its psychedelic compound RE104...

This year’s edition of the Benzinga Psychedelics Capital Conference, THE place to be for those interested or already involved in the space, will take place on April 13, following our established Cannabis Capital Conference (CCC), at the Fontainebleau Miami Beach Hotel in Florida....

After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.   And now, after 2022's enormous success, we are holding our second Benzinga...

Two Bills Approved By Hawaii Senators With Governor's Endorsement Hawaii Senate Ways and Means Committee approved a pair of bills aiming to promote and investigate the therapeutic potential of MDMA and psilocybin as an alternative to treat mental health conditions. The measures, which received...

Jeremy Gardner and Brock Pierce, managing partners at Mystic Ventures stopped by Benzinga Cannabis Insider where hosts Javier Hasse and Elliot Lane, asked them about their trajectory, from crypto to psychedelics, investment prospects in the sector, and the next key catalyzers for their legalization...

Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and added to the list of measures calling for some sort of psychedelics legalization, while...

Canadian biopharma psychedelics company Cube Psytech Holdings agreed to acquire Translational Life Sciences (TLS).  Cube will issue about 50% of its outstanding shares, warrants and options to shareholders, directors and employees of TLS in exchange for 100% of its outstanding share capital....

(Part three of a three-part series) See previous stories: Fox Rothschild Cannabis Attorney Analyzes Psychedelics Regs And Changing Public Perceptions Psychedelics Education, Rescheduling & Decriminalization As Seen By Fox Rothschild's Cannabis Partner Part one of our series discussed...

Australian Health Authority To Allow Psilocybin And MDMA-Assisted Therapy For Depression, PTSD Beginning on July 1, 2023, medicines containing psilocybin and MDMA can be prescribed by specifically authorized psychiatrists to treat certain mental health conditions, such as ...

Considering MDMA will likely be the first psychedelic to receive FDA approval for psychotherapeutic use to treat serious mental health conditions such as PTSD, several publicly listed companies are developing related products such as next-generation psychedelics- or a new delivery...

Silo Pharma Sees Growth In IP With New US Patent For Novel Ketamine Method On Stress-Induced Affective Disorders Psychedelics firm Silo Pharma Inc. (NASDAQ: SILO) has received a US patent covering claims on the use of proprietary ketamine-based drug SPC-15 for the treatment of stress-induced...

Cantor Fitzgerald's Pablo Zuanic hosted a virtual panel discussion about the psychedelics industry with three ketamine therapy providers: Irwin Naturals (OTCMKTS: IWINF)’ CEO Klee Irwin, Field Trip H&W (OTCMKTS: FTHWF)’s co-founder and director Mujeeb...